From: Impact of non-dialysis chronic kidney disease on survival in patients with septic shock
Survivors | Non-survivors | p | |
---|---|---|---|
n=70 | n=93 | ||
Male gender | 44 (63%) | 49 (53%) | 0.2 |
Age (years) | 64 (53–74) | 71 (59–77) | 0.01 |
Diabetes | 23 (33%) | 28 (30%) | 0.9 |
HBP | 39 (56%) | 58 (62%) | 0.4 |
Heart failure | 9 (13%) | 17 (18%) | 0.4 |
Peripheral artery disease | 12 (17%) | 13 (14%) | 0.8 |
Coronary artery disease | 11 (16%) | 17 (18%) | 0.8 |
COPD | 15 (21%) | 12 (13%) | 0.2 |
Statin use | 18 (26%) | 23 (25%) | 0.9 |
Baseline eGFR (ml/min/1.73m2) | 78 (61–106) | 63 (38–82) | 0.001 |
CKD | 17 (24%) | 39 (42%) | 0.03 |
Scr on admission (μmol/l) | 209 (122–409) | 290 (175–426) | 0.15 |
Scr at onset of septic shock (μmol/l) | 232 (117–384) | 270 (174–396) | 0.2 |
Hb on admission (g/dl) | 10.5 (8.2-12.7) | 10 (8.8-11.7) | 0.4 |
SAPS II | 50 (40–62) | 68 (56–90) | <0.001 |
Days w/o catechol (days) | 8 (3–14) | 0 (0–2) | <0.001 |
Days w/o MV (days) | 5 (2–8) | 0 (0–1) | <0.001 |
Length of stay, days | 12 (6–25) | 4 (1–10) | <0.001 |
RIFLE Classification | 59 (44%) | 76 (56%) | 0.08 |
Risk | 14 (56%) | 11 (44%) | 0.7 |
Injury | 14 (54%) | 12 (46%) | 0.8 |
Failure | 27 (35%) | 51 (65%) | 0.009 |
Loss of function | 4 (67%) | 2 (33%) | 0.7 |
ESKD | - | - | - |